TrialThe Journal of physiology2025

ColdZyme® reduces viral load and upper respiratory tract infection duration and protects airway epithelia from infection with human rhinoviruses.

Glen Davison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.